Michael FosselDr. Michael Fossel serves as chairman of the board of Telocyte, a biotech company developing telomerase therapy for Alzheimer's disease, with FDA-sponsored human trials planned to target the underlying disease process. His invited lecture at Harvard usiness School discussed Telocyte, age-related disease, and biotechnology.A recognized expert in aging and telomere biology, Dr. Fossel has authored over 100 scientific articles, book chapters, and books, and has lectured internationally, including at the National Institutes of Health. His 2020 article, A Unified Model of Dementias and Age-related Neurodegeneration, generated significant global interest with more than 1,000 reprint requests, presenting both a comprehensive understanding of dementia causation and novel therapeutic approaches. His companion work, A Unified Model of Age-Related Cardiovascular Disease, similarly explores potential interventions in cardiovascular disease.Dr. Fossel earned his BA and MA from Wesleyan University before completing his PhD in Neurobiology (1978) and MD (1981) at Stanford University, where he taught neuroanatomy and experimental design. He subsequently focused on aging, particularly premature aging syndromes and the experimental testing of aging theories. For nearly three decades, he served as Clinical Professor of Medicine and held leadership roles, including director of the American Aging Association and editor of several medical journals.His first book, Reversing Human Aging (1996), became an international bestseller. His comprehensive academic textbook, Cells, Aging, and Human Disease (Oxford University Press, 2004), features over 4,000 references and examines telomere biology and cellular senescence across multiple age-related diseases, including Alzheimer's disease, atherosclerosis, osteoporosis, and cancer. The Telomerase Revolution (2015) explores telomerase therapy as an intervention for age-related diseases and was recognized by both The London Times and Wall Street Journal as among the year's best science books. The work has been published in eight languages across eleven global editions. Most recently, Dr. Fossel served as editor and senior author of the Academic Press medical textbook Aging: Aging: How Aging Works, How We Can Reverse Aging, and Prospects for Curing Aging Diseases (2024), developed with distinguished co-authors from leading institutions including UCSF, Mayo Clinic, Harvard Medical School, and universities across three continents. He is also the editor and senior author of an upcoming 2027 text by World Scientific: Aging and Age-Reversal: The Prospects for Curing Age-Related Diseases. Read More Read Less